Keywords: LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AA; acrylic acid; Apo; apolipoprotein; BBB; blood-brain barrier; BCEC; brain capillary endothelial cells; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CNT; carbon nanotubes; FDA; U.S. Food and Drug Administration; GFAP; glial fibr
Keywords: Aβ; amyloid beta; AD; Alzheimer's disease; ADDL; amyloid-β-derived diffusible ligand; ALS; amyotrophic lateral sclerosis; ApoE; apolipoprotein E; ART; antiretroviral therapy; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebral spina
Keywords: Focused ultrasound; Blood-brain barrier; Nanoparticle; Microbubble; Drug delivery; PBCA;
Keywords: 60Co; Cobalt-60; 137Cs; Cesium-137; AuNPs; gold nanoparticles; β-CDC6; Amphiphilic β-cyclodextrin; Cu/LDPE; Copper/low-density polyethylene; DLS; dynamic light scattering; e-beam; electron beam; EO; Ethylene oxide; EDS; Energy-dispersive spectroscopy; E
Keywords: CME; Clathrin-mediated endocytosis; CvME; Caveolae-mediated endocytosis; DMPC; Dimyristoylphosphatidylcholine; DOPE; Dioleoylphosphatidylethanolamine; DPPC; Dipalmitoylphosphatidylcholine; DPPG; Dipalmitoylphosphatidylglycerol; DSPC; Distearoylphosphatidy
Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo
Keywords: PBCA; Nanoparticle; Blood-brain barrier; Toxicity; Human blood; Cytokine;
Agile delivery of protein therapeutics to CNS
Keywords: Aβ; amyloid β; Ab-InsR; antibodies against insulin receptor; Ab-TfR; antibodies against transferrin receptor; AD; Alzheimer's disease; Aerosol OT; bis-(2-ethylhexyl) sulfosucciate; ALS; amyotrophic lateral sclerosis; ApoB; apolipoprotein B; ApoE; apolip
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
Keywords: ABC; ATP-binding cassette super family pump; AIDS; acquired immunodeficiency syndrome; ALG; alginate; APBA; 3-aminophenyl boronic acid; API; active pharmaceutical ingredient; BBB; blood-brain barrier; BCSFB; blood-cerebrospinal fluid barrier; BPI-3; p
Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release
Keywords: Contraceptive; Drug combination; PLGA; PBCA; Organogel; Controlled release
Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity
Keywords: In vitro blood-brain barrier; Poly(n-butylcyano-acrylate); Transendothelial electrical resistance; Drug delivery; Nanoparticles; Polysorbate 80; BBB; blood-brain barrier; PBCA; Poly(n-butylcyano-acrylate; TEER; Transendothelial electrical resistance; PS80
Preparation and Evaluation of Poly-Butylcyanoacrylate Nanoparticles for Oral Delivery of Thymopentin
Keywords: thymopentin; oral drug delivery; bioavailability; PBCA; nanoparticles;
Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy
Keywords: PBCA; CTAB; pAFP-TK/GCV; Transfection; Bystander effect
Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography
Keywords: Nanoparticles; Polyalkylcyanoacrylate; PBCA; Molecular weight; Gel permeation chromatography; Size exclusion chromatography; Matrix-assisted laser desorption ionization time of flight mass spectrometry;
Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles
Keywords: D4T; stavudine; HIV; human immunodeficiency virus; LE; loading efficiency (%); MMA-SPM; methylmethacrylate-sulfopropylmethacrylate; NP; nanoparticle; NRTI; nucleoside reverse transcriptase inhibitor; PBCA; polybutylcyanoacrylate; PDI; polydispersity index